SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Dyadic International, Inc. (DYAI) News

Track canonical SquawkNews coverage tagged to DYAI, Dyadic International, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol DYAI Asset equity Sector Markets 90 days 6 Last 0.7727 Updated Aug 13, 2026, 12:02 PM UTC Open live news feed
L Dyadic International secures $2.9 million in offering Dyadic International, Inc. says it secured $2.9 million through a registered direct offering and concurrent private placement. MNA | Aug 13, 2026, 12:02 PM UTC L DYAI Announces Q2 2026 Financial Results DYAI announces second quarter 2026 financial results EARNINGS | Aug 12, 2026, 12:30 PM UTC M Dyadic Expands Non-Animal Dairy Pipeline Dyadic signs new development agreement EQUITY | Aug 04, 2026, 11:25 AM UTC L DYAI - Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 DYAI - Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 EARNINGS | Aug 03, 2026, 08:30 PM UTC L DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bun DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bundibugyo ebolavirus antigens to FBS and Scripps for preclinical evaluation EQUITY | Jul 28, 2026, 12:31 PM UTC L DYAI Dyadic international - expands Bio-industrial pipeline with new proprietary industrial enzyme program - To pursue commercialization thr DYAI Dyadic international - expands Bio-industrial pipeline with new proprietary industrial enzyme program - To pursue commercialization through sales, collaborations, manufacturing, and licensing EQUITY | Jul 16, 2026, 12:01 PM UTC